Blue Jet Health

how big is Blue Jet Health?

As of Jun 06, Blue Jet Healthcare Ltd has a market capitalization of 15,762.00 Cr, with recent net sales of 1029.99 Cr and a net profit of 305.21 Cr.

Market Cap: As of Jun 06, Blue Jet Healthcare Ltd has a market capitalization of 15,762.00 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Blue Jet Healthcare Ltd reported Net Sales of 1029.99 Cr and a Net Profit of 305.21 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: The Balance Sheet data is Consolidated and pertains to the latest annual period of Mar'21. The Shareholder's Funds are valued at 339.82 Cr, while the Total Assets amount to 536.27 Cr.

What does Blue Jet Health do?

Blue Jet Healthcare Ltd is a mid-cap company in the Pharmaceuticals & Biotechnology sector, reporting net sales of 340 Cr and a net profit of 110 Cr for March 2025. It was incorporated in 1968, rebranded in 2020, and has a market cap of Rs 15,577 Cr.

Overview:<BR>Blue Jet Healthcare Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Mid Cap company.<BR><BR>History:<BR>The company was originally incorporated as Jet Chemicals Private Limited in 1968. It changed its name to Blue Jet Healthcare Private Limited in December 2020 and became a Limited Company with its current name on May 18, 2022. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 340 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 110 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 15,577 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 52.00<BR>- Industry P/E: 53<BR>- Dividend Yield: 0.11%<BR>- Debt-Equity: -0.25<BR>- Return on Equity: 26.94%<BR>- Price to Book: 14.12<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are in the management team of Blue Jet Health?

As of March 2023, the management team of Blue Jet Health includes Akshay Bansarilal Arora (Executive Chairman), Shiven Akshay Arora (Managing Director), Naresh Suiyakant Shah (Executive Director), and several Independent Directors: Girish Paman Vanvari, Preeti Mehta, and Divya Momaya, along with Sweta Poddar (Company Secretary & Compliance Officer). Each member contributes to the company's governance and operations.

As of March 2023, the management team of Blue Jet Health includes the following individuals:<BR><BR>1. Akshay Bansarilal Arora - Executive Chairman<BR>2. Shiven Akshay Arora - Managing Director<BR>3. Naresh Suiyakant Shah - Executive Director<BR>4. Girish Paman Vanvari - Independent Director<BR>5. Preeti Mehta - Independent Director<BR>6. Divya Momaya - Independent Director<BR>7. Sweta Poddar - Company Secretary & Compliance Officer<BR><BR>Each member plays a crucial role in the governance and operational management of the company.

Has Blue Jet Health declared dividend?

Yes, Blue Jet Healthcare Ltd has declared a 50% dividend, amounting to 1 per share, with an ex-date of September 17, 2024. While the company has shown strong price returns of 80.89% over the last six months and 141.24% over the past year, dividend returns remain minimal.

Blue Jet Healthcare Ltd has declared a 50% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 50%<BR>- Amount per share: 1 per share<BR>- Ex-date: 17 Sep 24<BR><BR>Dividend Yield: 0.11%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 80.89%, with no dividend return, resulting in a total return of 80.89%.<BR><BR>Over the past year, the price return reached 141.24%, with a dividend return of 0.27%, leading to a total return of 141.51%.<BR><BR>For the 2-year period, there was no price return or dividend return, resulting in a total return of 0.0%.<BR><BR>In the 3-year period, there were no price or dividend returns, leading to a total return of 0.0%.<BR><BR>For the 4-year period, the price return and dividend return were both 0%, resulting in a total return of 0.0%.<BR><BR>In the 5-year period, there was no price return or dividend return, leading to a total return of 0.0%.<BR><BR>Overall, while Blue Jet Healthcare Ltd has declared a dividend, the company has shown significant price returns over the past year and six months, but the dividend returns have been minimal in comparison.

Who are the peers of the Blue Jet Health?

Blue Jet Health's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Neuland Labs, Sanofi India, Alivus Life, and Granules India. Blue Jet Health has the highest 1-year return at 139.99%, significantly outperforming its peers.

Peers: The peers of Blue Jet Health are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Neuland Labs., Sanofi India, Alivus Life, and Granules India.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, Neuland Labs., and Sanofi India, while Good management risk is found at Divi's Lab., Torrent Pharma, Blue Jet Health, Alivus Life, and Granules India. Below Average growth is noted for Divi's Lab., Torrent Pharma, Blue Jet Health, Sanofi India, Alivus Life, and Granules India, while Excellent growth is seen at Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, with Average growth at Neuland Labs. Capital Structure is Excellent for Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, Blue Jet Health, Neuland Labs., Sanofi India, Alivus Life, and Granules India, while Good capital structure is observed at Torrent Pharma.<BR><BR>Return Snapshot: Blue Jet Health has the highest 1-year return at 139.99%, while Sanofi India has the lowest at -28.96%. Blue Jet Health's return significantly outperforms all peers. Additionally, the six-month return is negative for Neuland Labs., Sanofi India, and Alivus Life.

When is the next results date for Blue Jet Health?

The next results date for Blue Jet Health is 22 July 2025.

The next results date for Blue Jet Health is scheduled for 22 July 2025.

Who are the top shareholders of the Blue Jet Health?

The top shareholder of Blue Jet Health is Akshay Bansarilal Arora, holding 68.99%. Other shareholders include mutual funds at 0.5%, foreign institutional investors at 1.97%, and individual investors with a collective holding of 8.03%.

The top shareholders of Blue Jet Health include the promoters, with Akshay Bansarilal Arora being the individual with the highest holding at 68.99%. Additionally, the company has mutual funds holding 0.5% through 8 schemes and foreign institutional investors (FIIs) holding 1.97% across 53 FIIs. Individual investors collectively hold 8.03% of the shares. There are no significant public shareholders listed.

Is Blue Jet Health technically bullish or bearish?

As of November 3, 2025, Blue Jet Health's technical trend has shifted to a moderately bearish stance, indicated by a bearish MACD, moving averages, and Bollinger Bands, suggesting a negative outlook in the near term.

As of 3 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Blue Jet Health is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a mildly bearish reading on the weekly Bollinger Bands. Additionally, the Dow Theory indicates a mildly bearish trend on the weekly chart. Overall, the combination of these indicators suggests a negative outlook for the stock in the near term.

How has been the historical performance of Blue Jet Health?

Blue Jet Health experienced a decline in net sales and profit from March 2020 to March 2021, with net sales dropping to 498.93 Cr from 538.20 Cr and profit after tax decreasing to 135.79 Cr from 144.96 Cr. Despite this, the company saw an increase in total assets and a significant rise in cash inflow.

Answer:<BR>The historical performance of Blue Jet Health shows a decline in net sales and profit from March 2020 to March 2021.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2021, Blue Jet Health reported net sales of 498.93 Cr, down from 538.20 Cr in the previous year. Total operating income also decreased to 498.93 Cr from 538.20 Cr. The raw material cost rose to 214.27 Cr from 186.60 Cr, while the total expenditure, excluding depreciation, fell to 292.88 Cr from 324.47 Cr. Operating profit (PBDIT) decreased slightly to 214.93 Cr from 219.54 Cr, and profit before tax declined to 184.66 Cr from 194.13 Cr. Consequently, profit after tax also dropped to 135.79 Cr from 144.96 Cr. The earnings per share (EPS) saw a significant reduction, falling to 27.4 from 483.2. On the balance sheet, total liabilities increased to 536.27 Cr from 373.85 Cr, while total assets rose to 536.27 Cr from 373.85 Cr. The company experienced a net cash inflow of 51.00 Cr in March 2021, compared to 5.00 Cr in March 2020, with closing cash and cash equivalents increasing to 61.00 Cr from 10.00 Cr.

Is Blue Jet Health overvalued or undervalued?

As of November 25, 2025, Blue Jet Health is considered very expensive and overvalued, with a PE ratio of 27.80 and lagging behind the Sensex with a year-to-date return of -0.49%.

As of 25 November 2025, Blue Jet Health's valuation grade has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE ratio of 27.80, an EV to EBIT of 22.46, and a Price to Book Value of 7.80, all of which suggest a high valuation relative to earnings and asset value.<BR><BR>In comparison to its peers, Blue Jet Health's valuation metrics are notably elevated; for instance, Poly Medicure has a PE ratio of 53.35 and an EV to EBITDA of 40.61, while Vimta Labs shows a PE of 44.86 and an EV to EBITDA of 24.04, both categorized as very expensive. The company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -0.49% compared to the Sensex's 8.25%, reinforcing the notion of overvaluation.

Are Blue Jet Healthcare Ltd latest results good or bad?

Blue Jet Healthcare Ltd's latest Q3 FY26 results are unfavorable, showing a 59.42% year-on-year decline in net profit and a 39.57% drop in net sales. The company's performance raises concerns about its financial health, with a negative outlook and significant stock underperformance.

Blue Jet Healthcare Ltd's latest results for Q3 FY26 indicate a significant decline in performance, which can be characterized as unfavorable. The company reported a net profit of ₹40.17 crore, reflecting a substantial decrease of 59.42% year-on-year and a 22.96% decline compared to the previous quarter. <BR><BR>Net sales also fell sharply, down 39.57% year-on-year to ₹192.41 crore, although there was a sequential improvement of 16.27% from the previous quarter. The operating margin has dropped to 24.36%, marking the lowest level in eight quarters, and the PAT margin decreased to 20.88%, down 1,021 basis points year-on-year.<BR><BR>These results represent a stark contrast to the company's strong performance in the first half of FY26, raising concerns about its operational challenges and overall financial health. The stock has underperformed significantly, down nearly 48% over the past year, which has led to a negative financial trend rating. Investors are left questioning whether this downturn is a temporary setback or indicative of deeper issues within the company. <BR><BR>Overall, the latest results suggest that Blue Jet Healthcare is currently facing serious challenges, making the outlook appear negative.

Should I buy, sell or hold Blue Jet Healthcare Ltd?

Why is Blue Jet Healthcare Ltd falling/rising?

As of 17-Mar, Blue Jet Healthcare Ltd's stock price is declining, currently at Rs 352.80, reflecting a 1.36% drop. The stock has underperformed significantly over the past year, with a 60.14% decline, and recent poor financial results have further eroded investor confidence.

As of 17-Mar, Blue Jet Healthcare Ltd's stock price is falling, currently at Rs 352.80, reflecting a decrease of Rs 4.85 or 1.36%. This decline is part of a broader trend, as the stock has been losing value for the past three days, with a total drop of 6.53% during this period. The stock is also trading close to its 52-week low, just 2.31% above Rs 344.65.<BR><BR>In terms of performance metrics, Blue Jet Healthcare has underperformed compared to the Sensex, with a 1-week return of -6.39% against the Sensex's -2.73%. Over the past year, the stock has experienced a significant decline of 60.14%, while the Sensex has gained 2.56%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>The company's recent financial results have also contributed to the negative sentiment. In the latest quarter, net sales fell by 34.7% compared to the previous four-quarter average, and profit after tax (PAT) dropped by 54.4%. This poor financial performance, combined with a long-term trend of underperformance against broader market indices, has led to a lack of investor confidence, further driving the stock price down.

Why is Blue Jet Healthcare Ltd falling/rising?

As of 18-Mar, Blue Jet Healthcare Ltd's stock price is rising to Rs 383.80, up 8.99%. This increase is driven by short-term factors like sector performance and heightened investor activity, despite previous declines in net sales and profits.

As of 18-Mar, Blue Jet Healthcare Ltd's stock price is rising, currently at Rs 383.80, reflecting a change of Rs 31.65 or 8.99%. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 5.84% today and has experienced a trend reversal, gaining after three consecutive days of decline. Additionally, the stock reached an intraday high of Rs 387.35, indicating strong buying interest.<BR><BR>Investor participation has also increased, with a delivery volume of 2.81 lacs on 17 March, which is up by 5.19% compared to the five-day average. This suggests a growing confidence among investors. Furthermore, the medical equipment sector, in which Blue Jet operates, has gained by 3.16%, contributing positively to the stock's performance.<BR><BR>Despite these positive indicators, it is important to note that the company has faced significant challenges, including a substantial decline in net sales and profits in the previous quarter. However, the current rise in stock price appears to be driven by short-term factors such as sector performance and increased trading activity rather than long-term fundamentals.

Why is Blue Jet Healthcare Ltd falling/rising?

As of 19-Mar, Blue Jet Healthcare Ltd's stock price is at 365.15, reflecting a decline of 4.86%. The stock has significantly underperformed both the market and its sector due to disappointing financial results and negative investor sentiment.

As of 19-Mar, Blue Jet Healthcare Ltd's stock price is falling, currently at 365.15, which reflects a decrease of 18.65 or 4.86%. This decline is evidenced by several factors. Over the past week, the stock has underperformed, showing a loss of 3.26% compared to a 2.40% decline in the Sensex. In the year-to-date, the stock has dropped significantly by 31.10%, while the broader market has only fallen by 12.92%. <BR><BR>The company's recent financial performance has also contributed to the negative sentiment. In the latest quarterly results, net sales fell by 34.7% compared to the previous four-quarter average, while profit before tax decreased by 60.7%, and profit after tax dropped by 54.4%. These disappointing results have raised concerns among investors about the company's future profitability.<BR><BR>Additionally, the stock has underperformed its sector, with a performance today that lagged behind by 1.79%. The stock touched an intraday low of Rs 363.2, indicating further selling pressure. Despite a rise in delivery volume, which increased by 36.16% against the five-day average, the overall market sentiment remains negative, particularly in the Medical Equipment/Supplies/Accessories sector, which has seen a decline of 3.07%.<BR><BR>Long-term performance also paints a bleak picture, with the stock generating a return of -59.98% over the past year and underperforming the BSE500 index over the last three years. This combination of poor financial results, sector underperformance, and negative market sentiment has led to the stock's current downward trajectory.

Why is Blue Jet Healthcare Ltd falling/rising?

As of 20-Mar, Blue Jet Healthcare Ltd's stock price is Rs 357.00, down 2.25%, and has lost 6.98% over the last two days. The stock is underperforming its sector and is close to its 52-week low, with recent poor financial results contributing to negative investor sentiment.

As of 20-Mar, Blue Jet Healthcare Ltd's stock price is falling, currently at Rs 357.00, reflecting a decrease of Rs 8.2 or 2.25%. The stock has been on a downward trend, having lost 6.98% over the last two days. Additionally, it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent decline in price momentum.<BR><BR>The stock's performance today has underperformed its sector by 2.9%, and it is close to its 52-week low, just 3.46% above Rs 344.65. Despite opening with a gain of 3.55% and reaching an intraday high of Rs 378.15, the stock quickly fell to a low of Rs 355.1, suggesting volatility and lack of sustained investor confidence.<BR><BR>The company's recent financial results have also contributed to the negative sentiment. In the latest quarter, net sales fell by 34.7% compared to the previous four-quarter average, and profit after tax (PAT) dropped by 54.4%. This poor performance is compounded by the stock's significant decline of 61.46% over the past year, which has led to a perception of below-par performance both in the near and long term.<BR><BR>Furthermore, there has been a decrease in investor participation, with delivery volume falling by 5.82% against the 5-day average, indicating waning interest from investors. Although the company has high management efficiency and a low debt-to-equity ratio, these positive factors are overshadowed by the recent negative financial results and overall stock performance.

Why is Blue Jet Healthcare Ltd falling/rising?

As of 23-Mar, Blue Jet Healthcare Ltd's stock price is at Rs. 340.85, down 4.72%, and has reached a 52-week low of Rs. 337. The stock's significant decline is attributed to poor financial results, underperformance against benchmarks, and decreased investor confidence.

As of 23-Mar, Blue Jet Healthcare Ltd's stock price is falling, currently at Rs. 340.85, reflecting a decrease of Rs. 16.9 or 4.72%. The stock has been on a downward trend, having lost 11.19% over the last three days and is trading significantly lower than its moving averages across various periods, indicating a persistent decline in value. <BR><BR>Today, the stock reached a new 52-week low of Rs. 337 and has underperformed its sector by 1.35%. The high volatility observed today, with an intraday fluctuation of 5.31%, suggests uncertainty among investors. Additionally, the stock has shown a substantial decline in performance over the past year, with a staggering 62.38% drop, which is significantly worse than the BSE500 index's performance.<BR><BR>The company's recent financial results have also contributed to the negative sentiment. For instance, net sales fell by 34.7%, while profit before tax and profit after tax dropped by 60.7% and 54.4%, respectively, compared to previous quarters. This underperformance, coupled with a decrease in investor participation—evidenced by an 8.77% drop in delivery volume—has further exacerbated the stock's decline. Overall, the combination of poor financial results, underperformance relative to benchmarks, and declining investor confidence has led to the falling stock price of Blue Jet Healthcare Ltd.

Why is Blue Jet Healthcare Ltd falling/rising?

As of 24-Mar, Blue Jet Healthcare Ltd's stock price is currently at Rs 347.65, showing a temporary rise after a trend reversal, but it has a year-to-date decline of 34.40% and significant long-term challenges. Despite recent gains and increased investor interest, the stock is underperforming its sector and trading below major moving averages, indicating ongoing struggles.

As of 24-Mar, Blue Jet Healthcare Ltd's stock price is rising, currently at Rs 347.65, reflecting an increase of Rs 6.6 or 1.94%. This upward movement follows a trend reversal after three consecutive days of decline. Notably, the stock opened with a gain of 4.1% today and reached an intraday high of Rs 355.05. Additionally, there has been a rise in investor participation, with delivery volume increasing by 17.29% compared to the five-day average, indicating growing interest in the stock.<BR><BR>Despite this positive movement today, the stock has faced significant challenges in the longer term, with a year-to-date decline of 34.40% and a staggering 61.55% drop over the past year. The stock is also trading close to its 52-week low, just 3.06% above it. Furthermore, it is currently underperforming its sector by 1.47%. The stock's performance is further complicated by its trading below all major moving averages, suggesting a bearish trend overall.<BR><BR>While the company has shown high management efficiency with a return on equity (ROE) of 23.50% and a low debt-to-equity ratio, the recent negative financial results, including a 34.7% drop in net sales and a 54.4% decline in profit after tax compared to previous quarters, have contributed to its long-term underperformance. Thus, while the stock is experiencing a temporary rise, the broader context indicates ongoing struggles that could impact its future performance.

Why is Blue Jet Healthcare Ltd falling/rising?

As of 25-Mar, Blue Jet Healthcare Ltd's stock price is currently at Rs 353.00, reflecting a short-term rise despite a significant long-term decline of 59.95% over the past year. The stock is underperforming relative to its moving averages and is close to its 52-week low, indicating a challenging environment for investors.

As of 25-Mar, Blue Jet Healthcare Ltd's stock price is rising, currently at Rs 353.00, reflecting an increase of Rs 5.35 or 1.54%. This rise can be attributed to a few key factors. Firstly, the stock has been gaining for the last two days, with a total return of 3.5% during this period. Additionally, it opened with a gain of 2.27% today and reached an intraday high of Rs 362, which is a 4.13% increase.<BR><BR>However, despite this short-term rise, the stock has been underperforming in the longer term, with a significant decline of 59.95% over the past year. It is also trading lower than its moving averages across various time frames, indicating a general downtrend. The stock is close to its 52-week low, being only 4.53% away from Rs 337.<BR><BR>Moreover, the sector in which Blue Jet operates, Medical Equipment/Supplies/Accessories, has seen a gain of 4.16%, which may be contributing to the stock's recent upward movement. Nonetheless, there is a notable decline in investor participation, with delivery volume falling by 14.99% compared to the 5-day average, which could signal caution among investors.<BR><BR>In summary, while Blue Jet Healthcare Ltd is experiencing a rise in its stock price in the short term, the overall performance metrics suggest a challenging environment, with significant long-term declines and underperformance relative to broader market indices.

Which are the latest news on Blue Jet Health?